Akram Abu-Okail is a M.Sc. graduate student researcher at Qassim University, College of Veterinary Medicine, Department of Pathology and Laboratory Diagnosis, Laboratory Diagnosis Program.
M.Sc. in Laboratory Diagnosis " Clinical Pathology "
Akram does research in Clinical and Molecular Pathology.
I am looking for potential International collaborators to work on joint research projects on clinical and molecular pathology.
EDUCATION
Bachelor of Veterinary Medicine
Diploma Of Veterinary General Surgery (Animal Surgery)
Master of Science in Laboratory Diagnosis " Clinical Pathology " (Veterinary Medicine)
RESEARCH, TEACHING, or OTHER INTERESTS
Pathology and Forensic Medicine, Veterinary, Medical Laboratory Technology, General Immunology and Microbiology
Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches Ayman Elbehiry, Eman Marzouk, Husam M. Edrees, Mai Ibrahem, Safiyah Alzahrani, et al. Microorganisms, 2026 Pseudomonas aeruginosa (P. aeruginosa) forms biofilms that are difficult to eliminate. The matrix protects the cells, efflux pumps reduce intracellular drug levels, and dormant subpopulations survive treatment. Routine minimum inhibitory concentration (MIC) testing does not account for these features, which helps explain why infections often continue even when therapy appears appropriate. This review describes how quorum-sensing (QS) and cyclic di-guanosine monophosphate (c-di-GMP) regulate matrix production, efflux activity, and dormancy within P. aeruginosa biofilms. Important matrix components, including Psl, Pel, alginate, and extracellular DNA, slow the movement of antimicrobial agents. Regulatory proteins such as sagS and brlR increase the activity of the MexAB-OprM and MexEF-OprN efflux systems, further reducing intracellular drug concentrations. Oxygen and nutrient limitation promote persister cells and viable but nonculturable cells, with both having the ability to survive antibiotic levels that would normally be lethal. These defenses explain the gap between MIC values and biofilm-specific measurements, such as the minimum biofilm inhibitory concentration and the minimum biofilm eradication concentration. This review also summarizes emerging antibiofilm strategies. These include QS inhibitors, compounds that lower c-di-GMP, such as nitric oxide donors, nanoparticles, depolymerases, bacteriophages, and therapies that are directed at host targets. Modern diagnostic tools, such as confocal laser scanning microscopy, optical coherence tomography, and Raman spectroscopy, improve detection and guide treatment planning. A staged therapeutic approach is presented that begins with the dispersal or loosening of the matrix, continues with targeted antibiotics, and concludes with support for immune clearance. Viewing these strategies within a One Health framework highlights the role of biofilms in clinical disease and in environmental reservoirs and supports more effective surveillance and prevention.
Next-Generation Sequencing for Bloodstream Infections: Shaping the Future of Rapid Diagnostics and Precision Medicine Ayman Elbehiry, Eman Marzouk, Husam M. Edrees, Moustafa H. Abdelsalam, Feras Aljizani, et al. Diagnostics, 2025 Bloodstream infections and sepsis necessitate rapid, sensitive, and clinically relevant diagnostics to minimize treatment delays and improve clinical outcomes. Next-generation sequencing enables culture-independent pathogen detection, antimicrobial resistance profiling, and genome-informed epidemiology. This narrative review integrates clinical evidence with practical workflows across three complementary approaches. We describe the use of plasma microbial cell-free DNA for broad organism detection and burden monitoring, as well as metagenomic next-generation sequencing of blood or plasma for unbiased pathogen discovery, including culture-negative and polymicrobial infections. Same-day Oxford Nanopore Technologies sequencing of positive blood culture broth is also discussed as a way to accelerate species identification, targeted resistance reporting, and infection-prevention decisions. We outline the sample-to-result steps, typical turnaround time (TAT), and stewardship-aligned decision points. Analytical reliability depends on effective reduction in human DNA background, stringent control of background and reagent-derived nucleic acids in low-biomass samples, and documented and validated bioinformatics workflows that are supported by curated taxonomic and resistance databases. Quantitative reports should adhere to validated thresholds and should be interpreted in the context of internal controls and clinical pretest probability. Ongoing challenges include variable correlation between genotype and phenotype for specific pathogen and antibiotic pairs, interpretation of low-level signals, and inconsistent regulatory and reimbursement environments. Advances in portable sequencing, faster laboratory and analytical workflows, and scaled liquid biopsy strategies may further reduce the TAT and expand access. Integrating these tools within One Health frameworks and global genomic surveillance programs could support early resistance detection and coordinated public health action, which could help to advance sepsis care toward more precise treatment and real-time infection control insights.
Emerging Technologies and Integrated Strategies for Microbial Detection and Control in Fresh Produce Ayman Elbehiry, Eman Marzouk, Feras Alzaben, Abdulaziz Almuaither, Banan Abead, et al. Microorganisms, 2025 The global consumption of fresh and ready-to-eat (RTE) fruits and vegetables has surged due to increasing awareness of their nutritional benefits. However, this trend has been accompanied by a rise in foodborne illness outbreaks linked to microbial contamination. This narrative review synthesizes current knowledge on the prevalence and diversity of foodborne pathogens in fresh produce, including bacterial, viral, and fungal agents. It critically evaluates both conventional and emerging detection methods, ranging from culture-based techniques and immunoassays to advanced molecular diagnostics, biosensors, flow cytometry (FC), and hyperspectral imaging (HSI). Additionally, this review discusses cutting-edge control strategies, such as natural antifungal agents, essential oils, biocontrol methods, and non-thermal technologies like cold plasma and UV-C treatment. Emphasis is placed on sampling methodologies, sustainability, One Health perspectives, and regulatory considerations. By highlighting recent technological advances and their limitations, this review aims to support the development of integrated, effective, and safe microbial control approaches for the fresh produce supply chain.
Microbial Food Safety and Antimicrobial Resistance in Foods: A Dual Threat to Public Health Ayman Elbehiry, Eman Marzouk, Adil Abalkhail, Husam M. Edrees, Abousree T. Ellethy, et al. Microorganisms, 2025 The intersection of microbial food safety and antimicrobial resistance (AMR) represents a mounting global threat with profound implications for public health, food safety, and sustainable development. This review explores the complex pathways through which foodborne pathogens—such as Salmonella spp., Escherichia coli (E. coli), Listeria monocytogenes (L. monocytogenes), and Campylobacter spp.—acquire and disseminate resistance within human, animal, and environmental ecosystems. Emphasizing a One Health framework, we examine the drivers of AMR across sectors, including the misuse of antibiotics in agriculture, aquaculture, and clinical settings, and assess the role of environmental reservoirs in sustaining and amplifying resistance genes. We further discuss the evolution of surveillance systems, regulatory policies, and antimicrobial stewardship programs (ASPs) designed to mitigate resistance across the food chain. Innovations in next-generation sequencing, metagenomics, and targeted therapeutics such as bacteriophage therapy, antimicrobial peptides (AMPs), and CRISPR-based interventions offer promising alternatives to conventional antibiotics. However, the translation of these advances into practice remains uneven, particularly in low- and middle-income countries (LMICs) facing significant barriers to diagnostic access, laboratory capacity, and equitable treatment availability. Our analysis underscores the urgent need for integrated, cross-sectoral action—anchored in science, policy, and education—to curb the global spread of AMR. Strengthening surveillance, investing in research, promoting responsible antimicrobial use, and fostering global collaboration are essential to preserving the efficacy of existing treatments and ensuring the microbiological safety of food systems worldwide.
Green-synthesized silver nanoparticles from edible plant extracts ameliorate cadmium chloride-induced hepatorenal and testicular toxicity in rats Akram Abu-Okail, Abdullah S. M. Aljohani, Ayman M. Mousa, Heba A. S. El-Nashar, Mohamed El-Shazly, et al. Frontiers in Cell and Developmental Biology, 2025 Background Cadmium (Cd) is widely known as an environmental toxicant, ranked as the seventh most toxic heavy metal. Exposure to cadmium through inhalation and ingestion can lead to serious health issues, including liver damage, kidney degeneration, testicular problems, and blood disorders in both humans and animals. Objective This study aimed to evaluate the protective effects of biosynthesized silver nanoparticles (AgNPs) against cadmium chloride-induced hepatic, renal, and reproductive toxicity in male rats. Methods AgNPs were synthesized via chemical reduction in silver nitrate using a combination of three plant extracts, namely, Petroselinum crispum , Zea mays silk, and Acacia senegal . The obtained AgNPs were characterized and subjected to an in vivo study. Forty healthy adult male albino rats (200–230 g) were divided into four groups (n = 10): G1: negative control, G2: rats received AgNPs (200 mg/kg b.w), G3: rats received cadmium chloride (5 mg/kg b.w), and G4: rats received AgNPs (200 mg/kg b.w.) followed by cadmium chloride (5 mg/kg b.w) after 90 min. All treatments were administered daily for 35 days. Biochemical assessments included liver enzymes (alanine transaminase, aspartate aminotransferase, and alkaline phosphatase), kidney markers (urea and creatinine), testicular hormones (testosterone, luteinizing hormone, and follicle-stimulating hormone), lipid profile (low-density lipoprotein, high-density lipoprotein, and triglyceride), and antioxidant markers (total antioxidants and malondialdehyde). Histopathological studies were performed on the liver, kidney, and testicular tissues. Results Synthesized AgNPs exhibited spherical morphology, with an average nanosize distribution of 5.28–21.47 nm. Cadmium chloride exposure significantly elevated liver enzymes, lipid markers, urea, creatinine, and MDA while decreasing testicular hormone levels (testosterone and luteinizing hormone), indicating hepato-renal and testicular damage, alongside histopathological damage in all examined organs. Co-administration of AgNPs markedly ameliorated these biochemical alterations, improving liver and kidney function, restoring total antioxidant capacity, and normalizing lipid, protein, and testicular hormone profiles. Histopathological results revealed that treatment with AgNPs restored the angiopathic, degenerative, and necrotic changes prompted by cadmium chloride administration. Conclusion AgNPs biosynthesized from combined extracts of P. crispum , Z. mays silk, and A. senegal demonstrated significant protective effects against cadmium chloride-induced toxicity. Their antioxidant and free radical scavenging properties suggest potential therapeutic value in mitigating environmental cadmium toxicity.
Detection of antimicrobial resistance via state-of-the-art technologies versus conventional methods Ayman Elbehiry, Eman Marzouk, Adil Abalkhail, Moustafa H. Abdelsalam, Mohamed E. A. Mostafa, et al. Frontiers in Microbiology, 2025 Antimicrobial resistance (AMR) is recognized as one of the foremost global health challenges, complicating the treatment of infectious diseases and contributing to increased morbidity and mortality rates. Traditionally, microbiological culture and susceptibility testing methods, such as disk diffusion and minimum inhibitory concentration (MIC) assays, have been employed to identify AMR bacteria. However, these conventional techniques are often labor intensive and time consuming and lack the requisite sensitivity for the early detection of resistance. Recent advancements in molecular and genomic technologies—such as next-generation sequencing (NGS), matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS), lateral flow immunoassays (LFIAs), PCR-based diagnostic methods, and CRISPR-based diagnostics—have revolutionized the diagnosis of AMR. These innovative approaches provide increased sensitivity, reduced turnaround times, and the ability to identify genetic resistance mechanisms. This review seeks to examine the advantages and disadvantages of both emerging technologies and traditional methods for detecting AMR, emphasizing the potential benefits and limitations inherent to each. By understanding the strengths and limitations of these technologies, stakeholders, including researchers, healthcare professionals, regulatory agencies, health authorities, financial managers, and patients, can make informed decisions aimed at preventing the emergence and dissemination of antibiotic-resistant strains, thereby ultimately increasing patient safety.
Advancing the fight against tuberculosis: integrating innovation and public health in diagnosis, treatment, vaccine development, and implementation science Ayman Elbehiry, Eman Marzouk, Husam M. Edrees, Riyad AlShaqi, Abousree T. Ellethy, et al. Frontiers in Medicine, 2025 Tuberculosis (TB) remains one of the leading causes of infectious disease mortality worldwide, increasingly complicated by the emergence of drug-resistant strains and limitations in existing diagnostic and therapeutic strategies. Despite decades of global efforts, the disease continues to impose a significant burden, particularly in low- and middle-income countries (LMICs) where health system weaknesses hinder progress. This comprehensive review explores recent advancements in TB diagnostics, antimicrobial resistance (AMR surveillance), treatment strategies, and vaccine development. It critically evaluates cutting-edge technologies including CRISPR-based diagnostics, whole-genome sequencing, and digital adherence tools, alongside therapeutic innovations such as shorter multidrug-resistant TB regimens and host-directed therapies. Special emphasis is placed on the translational gap—highlighting barriers to real-world implementation such as cost, infrastructure, and policy fragmentation. While innovations like the Xpert MTB/RIF Ultra, BPaLM regimen, and next-generation vaccines such as M72/AS01E represent pivotal progress, their deployment remains uneven. Implementation science, cost-effectiveness analyses, and health equity considerations are vital to scaling up these tools. Moreover, the expansion of the TB vaccine pipeline and integration of AI in diagnostics signal a transformative period in TB control. Eliminating TB demands more than biomedical breakthroughs—it requires a unified strategy that aligns innovation with access, equity, and sustainability. By bridging science with implementation, and integrating diagnostics, treatment, and prevention within robust health systems, the global community can accelerate the path toward ending TB.
Enterobacter cloacae from urinary tract infections: frequency, protein analysis, and antimicrobial resistance Ayman Elbehiry, Mansor Al Shoaibi, Hamzah Alzahrani, Mai Ibrahem, Ihab Moussa, et al. AMB Express, 2024 The genus Enterobacter belongs to the ESKAPE group, which includes Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. This group is characterized by the development of resistance to various antibiotics. In recent years, Enterobacter cloacae (E. cloacae) has emerged as a clinically important pathogen responsible for a wide range of healthcare-associated illnesses. Identifying Enterobacter species can be challenging due to their similar phenotypic characteristics. The emergence of multidrug-resistant E. cloacae is also a significant problem in healthcare settings. Therefore, our study aimed to identify and differentiate E. cloacae using Matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) as a fast and precise proteomic analytical technique. We also tested hospital-acquired E. cloacae isolates that produce Extended-spectrum beta-lactamases (ESBL) against commonly used antibiotics for treating urinary tract infections (UTIs). We used a total of 189 E. cloacae isolates from 2300 urine samples of patients with UTIs in our investigation. We employed culturing techniques, as well as the BD Phoenix™ automated identification system (Becton, Dickinson) and Analytical Profile Index (API) system for the biochemical identification of E. cloacae isolates. We used the MALDI Biotyper (MBT) device for peptide mass fingerprinting analysis of all isolates. We utilized the single peak intensities and Principal Component Analysis (PCA) created by MBT Compass software to discriminate and cluster the E. cloacae isolates. Additionally, we evaluated the sensitivity and resistance of ESBL-E. cloacae isolates using the Kirby Bauer method. Out of the 189 E. cloacae isolates, the BD Phoenix system correctly identified 180 (95.24%) isolates, while the API system correctly identified 165 (87.30%) isolates. However, the MBT accurately identified 185 (98.95%) isolates with a score of 2.00 or higher. PCA positively discriminated the identified E. cloacae isolates into one group, and prominent peaks were noticed between 4230 mass-to-charge ratio (m/z) and 8500 m/z. The ESBL-E. cloacae isolates exhibited a higher degree of resistance to ampicillin, amoxicillin-clavulanate, cephalothin, cefuroxime, and cefoxitin. Several isolates were susceptible to carbapenems (meropenem, imipenem, and ertapenem); however, potential future resistance against carbapenems should be taken into consideration. In conclusion, MALDI-TOF MS is a powerful and precise technology that can be routinely used to recognize and differentiate various pathogens in clinical samples. Additionally, the growing antimicrobial resistance of this bacterium may pose a significant risk to human health.
Proteome analysis, genetic characterization, and antibiotic resistance patterns of Klebsiella pneumoniae clinical isolates Eman Marzouk, Adil Abalkhail, Jamaan ALqahtani, Khalid Alsowat, Menwer Alanazi, et al. AMB Express, 2024 Klebsiella pneumoniae (K. pneumoniae) is a member of the ESKAPE group and is responsible for severe community and healthcare-associated infections. Certain Klebsiella species have very similar phenotypes, which presents a challenge in identifying K. pneumoniae. Multidrug-resistant K. pneumoniae is also a serious global problem that needs to be addressed. A total of 190 isolates were isolated from urine (n = 69), respiratory (n = 52), wound (n = 48) and blood (n = 21) samples collected from various hospitals in the Al-Qassim, Saudi Arabia, between March 2021 and October 2022. Our study aimed to rapidly and accurately detect K. pneumoniae using the Peptide Mass Fingerprinting (PMF) technique, confirmed by real-time PCR. Additionally, screening for antibiotic susceptibility and resistance was conducted. The primary methods for identifying K. pneumoniae isolates were culture, Gram staining, and the Vitek® 2 ID Compact system. An automated MALDI Biotyper (MBT) instrument was used for proteome identification, which was subsequently confirmed using SYBR green real-time polymerase chain reaction (real-time PCR) and microfluidic electrophoresis assays. Vitek® 2 AST-GN66 cards were utilized to evaluate the antimicrobial sensitivity of K. pneumoniae isolates. According to our results, Vitek® 2 Compact accurately identified 178 out of 190 (93.68%) K. pneumoniae isolates, while the PMF technique correctly detected 188 out of 190 (98.95%) isolates with a score value of 2.00 or higher. Principal component analysis was conducted using MBT Compass software to classify K. pneumoniae isolates based on their structure. Based on the analysis of the single peak intensities generated by MBT, the highest peak values were found at 3444, 5022, 5525, 6847, and 7537 m/z. K. pneumoniae gene testing confirmed the PMF results, with 90.53% detecting entrobactin, 70% detecting 16 S rRNA, and 32.63% detecting ferric iron uptake. The resistance of the K. pneumoniae isolates to antibiotics was as follows: 64.75% for cefazolin, 62.63% for trimethoprim/sulfamethoxazole, 59.45% for ampicillin, 58.42% for cefoxitin, 57.37% for ceftriaxone, 53.68% for cefepime, 52.11% for ampicillin-sulbactam, 50.53% for ceftazidime, 52.11% for ertapenem, and 49.47% for imipenem. Based on the results of the double-disk synergy test, 93 out of 190 (48.95%) K. pneumoniae isolates were extended-spectrum beta-lactamase. In conclusion, PMF is a powerful analytical technique used to identify K. pneumoniae isolates from clinical samples based on their proteomic characteristics. K. pneumoniae isolates have shown increasing resistance to antibiotics from different classes, including carbapenem, which poses a significant threat to human health as these infections may become difficult to treat.
Therapeutic Impact of Plant-Derived Extracts and their Silver Nanoparticle-Loaded Extracts on the Zoonotic Parasite Hymenolepis Nana Infection WMA Elgendy, HM El-Wahsh, D Naguib, RA Elmahy, SAAG Morsy, ... Acta Parasitologica 71 (2), 78 , 2026 2026
Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches A Elbehiry, E Marzouk, HM Edrees, M Ibrahem, S Alzahrani, ... Microorganisms 14 (1), 109 , 2026 2026 Citations: 5
Green-synthesized silver nanoparticles from edible plant extracts ameliorate cadmium chloride-induced hepatorenal and testicular toxicity in rats A Abu-Okail, ASM Aljohani, AM Mousa, HAS El-Nashar, M El-Shazly, ... Frontiers in Cell and Developmental Biology 13, 1677434 , 2025 2025 Citations: 1
Next-Generation Sequencing for Bloodstream Infections: Shaping the Future of Rapid Diagnostics and Precision Medicine A Elbehiry, E Marzouk, HM Edrees, MH Abdelsalam, F Aljizani, S Alqarni, ... Diagnostics 15 (23), 2944 , 2025 2025 Citations: 2
Advancing the fight against tuberculosis: integrating innovation and public health in diagnosis, treatment, vaccine development, and implementation science A Elbehiry, E Marzouk, HM Edrees, R AlShaqi, AT Ellethy, F Alzaben, ... Frontiers in Medicine 12, 1596579 , 2025 2025 Citations: 15
Microbial food safety and antimicrobial resistance in foods: a dual threat to public health A Elbehiry, E Marzouk, A Abalkhail, HM Edrees, AT Ellethy, AM Almuzaini, ... Microorganisms 13 (7), 1592 , 2025 2025 Citations: 52
Emerging Technologies and Integrated Strategies for Microbial detection and control in fresh produce A Elbehiry, E Marzouk, F Alzaben, A Almuaither, B Abead, M Alamri, ... Microorganisms 13 (7), 1447 , 2025 2025 Citations: 20
Detection of antimicrobial resistance via state-of-the-art technologies versus conventional methods A Elbehiry, E Marzouk, A Abalkhail, MH Abdelsalam, MEA Mostafa, ... Frontiers in microbiology 16, 1549044 , 2025 2025 Citations: 53
Pivotal role of Helicobacter pylori virulence genes in pathogenicity and vaccine development A Elbehiry, E Marzouk, A Abalkhail, W Sindi, Y Alzahrani, S Alhifani, ... Frontiers in Medicine 11, 1523991 , 2025 2025 Citations: 13
Proteome analysis, genetic characterization, and antibiotic resistance patterns of Klebsiella pneumoniae clinical isolates E Marzouk, A Abalkhail, J ALqahtani, K Alsowat, M Alanazi, F Alzaben, ... AMB Express 14 (1), 54 , 2024 2024 Citations: 14
Enterobacter cloacae from urinary tract infections: frequency, protein analysis, and antimicrobial resistance A Elbehiry, M Al Shoaibi, H Alzahrani, M Ibrahem, I Moussa, F Alzaben, ... AMB Express 14 (1), 17 , 2024 2024 Citations: 29
Using Protein Fingerprinting for Identifying and Discriminating Methicillin Resistant Staphylococcus aureus Isolates from Inpatient and Outpatient Clinics A Elbehiry, E Marzouk, I Moussa, S Anagreyyah, A AlGhamdi, A Alqarni, ... Diagnostics 13 (17), 2825 , 2023 2023 Citations: 11
Molecular characteristics and zoonotic potential of enteric protists in domestic dogs and cats in Egypt EK Elmahallawy, A Gareh, A Abu-Okail, PC Köster, A Dashti, J Asseri, ... Frontiers in Veterinary Science 10, 1229151 , 2023 2023 Citations: 15
The Prevalence of Multidrug-Resistant Acinetobacter baumannii and Its Vaccination Status among Healthcare Providers A Elbehiry, E Marzouk, I Moussa, Y Mushayt, AA Algarni, OA Alrashed, ... Vaccines 11 (7), 1171 , 2023 2023 Citations: 41
An overview of the public health challenges in diagnosing and controlling human foodborne pathogens A Elbehiry, A Abalkhail, E Marzouk, AE Elmanssury, AM Almuzaini, ... Vaccines 11 (4), 725 , 2023 2023 Citations: 207
Helicobacter pylori Infection: Current Status and Future Prospects on Diagnostic, Therapeutic and Control Challenges A Elbehiry, E Marzouk, M Aldubaib, A Abalkhail, S Anagreyyah, N Anajirih, ... Antibiotics 12 (2), 191 , 2023 2023 Citations: 274
MOST CITED SCHOLAR PUBLICATIONS
Helicobacter pylori Infection: Current Status and Future Prospects on Diagnostic, Therapeutic and Control Challenges A Elbehiry, E Marzouk, M Aldubaib, A Abalkhail, S Anagreyyah, N Anajirih, ... Antibiotics 12 (2), 191 , 2023 2023 Citations: 274
An overview of the public health challenges in diagnosing and controlling human foodborne pathogens A Elbehiry, A Abalkhail, E Marzouk, AE Elmanssury, AM Almuzaini, ... Vaccines 11 (4), 725 , 2023 2023 Citations: 207
Detection of antimicrobial resistance via state-of-the-art technologies versus conventional methods A Elbehiry, E Marzouk, A Abalkhail, MH Abdelsalam, MEA Mostafa, ... Frontiers in microbiology 16, 1549044 , 2025 2025 Citations: 53
Microbial food safety and antimicrobial resistance in foods: a dual threat to public health A Elbehiry, E Marzouk, A Abalkhail, HM Edrees, AT Ellethy, AM Almuzaini, ... Microorganisms 13 (7), 1592 , 2025 2025 Citations: 52
The Prevalence of Multidrug-Resistant Acinetobacter baumannii and Its Vaccination Status among Healthcare Providers A Elbehiry, E Marzouk, I Moussa, Y Mushayt, AA Algarni, OA Alrashed, ... Vaccines 11 (7), 1171 , 2023 2023 Citations: 41
Enterobacter cloacae from urinary tract infections: frequency, protein analysis, and antimicrobial resistance A Elbehiry, M Al Shoaibi, H Alzahrani, M Ibrahem, I Moussa, F Alzaben, ... AMB Express 14 (1), 17 , 2024 2024 Citations: 29
Emerging Technologies and Integrated Strategies for Microbial detection and control in fresh produce A Elbehiry, E Marzouk, F Alzaben, A Almuaither, B Abead, M Alamri, ... Microorganisms 13 (7), 1447 , 2025 2025 Citations: 20
Advancing the fight against tuberculosis: integrating innovation and public health in diagnosis, treatment, vaccine development, and implementation science A Elbehiry, E Marzouk, HM Edrees, R AlShaqi, AT Ellethy, F Alzaben, ... Frontiers in Medicine 12, 1596579 , 2025 2025 Citations: 15
Molecular characteristics and zoonotic potential of enteric protists in domestic dogs and cats in Egypt EK Elmahallawy, A Gareh, A Abu-Okail, PC Köster, A Dashti, J Asseri, ... Frontiers in Veterinary Science 10, 1229151 , 2023 2023 Citations: 15
Proteome analysis, genetic characterization, and antibiotic resistance patterns of Klebsiella pneumoniae clinical isolates E Marzouk, A Abalkhail, J ALqahtani, K Alsowat, M Alanazi, F Alzaben, ... AMB Express 14 (1), 54 , 2024 2024 Citations: 14
Pivotal role of Helicobacter pylori virulence genes in pathogenicity and vaccine development A Elbehiry, E Marzouk, A Abalkhail, W Sindi, Y Alzahrani, S Alhifani, ... Frontiers in Medicine 11, 1523991 , 2025 2025 Citations: 13
Using Protein Fingerprinting for Identifying and Discriminating Methicillin Resistant Staphylococcus aureus Isolates from Inpatient and Outpatient Clinics A Elbehiry, E Marzouk, I Moussa, S Anagreyyah, A AlGhamdi, A Alqarni, ... Diagnostics 13 (17), 2825 , 2023 2023 Citations: 11
Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches A Elbehiry, E Marzouk, HM Edrees, M Ibrahem, S Alzahrani, ... Microorganisms 14 (1), 109 , 2026 2026 Citations: 5
Next-Generation Sequencing for Bloodstream Infections: Shaping the Future of Rapid Diagnostics and Precision Medicine A Elbehiry, E Marzouk, HM Edrees, MH Abdelsalam, F Aljizani, S Alqarni, ... Diagnostics 15 (23), 2944 , 2025 2025 Citations: 2
Green-synthesized silver nanoparticles from edible plant extracts ameliorate cadmium chloride-induced hepatorenal and testicular toxicity in rats A Abu-Okail, ASM Aljohani, AM Mousa, HAS El-Nashar, M El-Shazly, ... Frontiers in Cell and Developmental Biology 13, 1677434 , 2025 2025 Citations: 1
Therapeutic Impact of Plant-Derived Extracts and their Silver Nanoparticle-Loaded Extracts on the Zoonotic Parasite Hymenolepis Nana Infection WMA Elgendy, HM El-Wahsh, D Naguib, RA Elmahy, SAAG Morsy, ... Acta Parasitologica 71 (2), 78 , 2026 2026
